SCHEMBL17933355

SCHEMBL17933355

C[C@@H](N)Cc1ncc(P(=O)(O)O)o1

nearest known ligand 0.38

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ FBP1 P09467 20/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16561819 0.87 FBP1 (0.34) FBP1
SCHEMBL18534217 0.69 RXRA (0.50) —
SCHEMBL17933354 0.68 ALDH1A1 (0.33) FBP1
SCHEMBL17933360 0.66 ALDH1A1 (0.32) FBP1
SCHEMBL17933366 0.66 FDPS (0.35) FBP1
SCHEMBL17933349 0.66 SCN10A (0.39) —
SCHEMBL17933358 0.65 ALDH1A1 (0.31) FBP1
SCHEMBL17933370 0.65 FDPS (0.38) FBP1
SCHEMBL14478192 0.59 — —
SCHEMBL17933367 0.58 TAAR1 (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160207948-A1 PHOSPHOHISTIDINE AND PHOSPHOTYROSINE ANALOGUES UNIVERSITY OF SHEFFIELD (GB) 2016-07-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160207948-A1 PHOSPHOHISTIDINE AND PHOSPHOTYROSINE ANALOGUES HRH3, CYTH3, CYTH2 FBP1 1675/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback